Markets finish week down after bouncing on Bannon's exit >>> READ MORE

3 Huge Healthcare Trends Can Fatten Your Portfolio

Invest in healthcare trends

    View All  

Drugmakers and the Obesity Market

When it comes to the drug industry, three heavyweights basically corner the market for obesity treatments: Xenical from Roche (RHHBY), Belviq  from  Arena Pharmaceuticals (ARNA) and Qsymia, a product of Vivus (VVUS).

Not expected to gain FDA approval until 2014 or 2015, Contrave from Orexigen (OREX) may eventually give the others a run for their money but not in the short-term.

Unfortunately, no matter how we choose to prevent and treat obesity, the real battle has just begun. Good, bad or otherwise, so has the uptrend in related stocks.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC